Advertisement

Synthetic Estrogens and Liver Cancer: Risk Analysis of Animal and Human Data

  • Jonathan J. Li
  • Hadley Kirkman
  • Sara Antonia Li

Abstract

In 1971, Baum et al. (1) reported a causal relationship between estrogen exposure and hepatic tumors in women. At that time, there was little or no evidence available indicating that liver tumors could be induced following prolonged estrogen treatment in experimental animals, even at high doses (2–5). Nevertheless, over the years, epidemiologic evidence continued to accumulate that supported this initial causal association in humans following the therapeutic use of estrogens in the liver (6–13). The present report summarizes the human data, largely in women, regarding the association of liver tumor incidences and estrogen intake. In addition, we present heretofore unpublished observations concerning liver tumor incidences in male and female hamsters exposed to various natural and synthetic estrogens in the absence of any other intervening agent.

Keywords

Oral Contraceptive Liver Tumor Focal Nodular Hyperplasia Syrian Golden Hamster Estrogen Exposure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Baum JK, Holtz F, Bookstein JJ, Klein EW (1973) Possible association between benign hepatomas and oral contraceptives. Lancet 926–929.Google Scholar
  2. 2.
    Gibson JP, Newberne JW, Kuhir WL, Elsea JR (1967) Comparative chronic toxicology of three oral estrogens in rats. Toxicol Appl Pharmacol 11: 489–510.PubMedCrossRefGoogle Scholar
  3. 3.
    Schardein JL, Kaump DH, Woosley ET, Jellema MM (1970) Long term toxicologic and tumorigenesis studies on an oral contraceptive agent in albino rats. Toxical Appl Pharmacol 16: 10–23.CrossRefGoogle Scholar
  4. 4.
    Heston WE, Vlahakis G, Desmukes B (1973) Effect of the antifertility drug Enovid in female strains of mice with particular regard to carcinogenesis. J Natl Cancer Inst 51: 209–224.PubMedGoogle Scholar
  5. 5.
    Barrows GH, Christopherson WM, Drill VA (1977) Liver lesions and oral contraceptives steroids. J Toxicol Environ Health 3: 219–230.PubMedCrossRefGoogle Scholar
  6. 6.
    Nissen ED, Kent DR (1975) Liver tumors and oral contraceptives. Obst Gynecol 46: 460–467.Google Scholar
  7. 7.
    Sotaniemi EA, Alavaikko MJ, Kaipainen WJ (1975) Primary liver cancer associated with long-term oestrogen therapy. Ann Clin Res 7: 287–289.PubMedGoogle Scholar
  8. 8.
    Edmundson HA, Henderson B, Benton B (1976) Liver cell adenomas associated with use of oral contraceptives. New Engl J Med 294: 470–472.CrossRefGoogle Scholar
  9. 9.
    Pryor AC, Cohen RJ, Goldman RL (1977) Hepatocellular carcinoma in a woman on long-term oral contraceptives. Cancer 40: 884–888.PubMedCrossRefGoogle Scholar
  10. 10.
    Aungst CW (1978) Benign liver tumors and oral contraceptives. New York State J Med 78: 1933–1934.Google Scholar
  11. 11.
    Vana J, Murphy GP (1979) Primary malignant liver tumors. Association with oral contraceptives. New York J Med 79: 321–325.PubMedGoogle Scholar
  12. 12.
    Brooks JJ (1982) Hepatoma associated with diethylstilbestrol therapy for prostatic carcinoma. J Urology 128: 1044–1045.Google Scholar
  13. 13.
    Endo H, Murakarni T, Nishimoto I, Sekine I, Yokoyamo M (1987) Multicentric hepatocellular carcinoma following phosphate diethylstilbestrol therapy for prostatic cancer. Acta Pathol Jpn 37: 795–806.PubMedGoogle Scholar
  14. 14.
    Edmundson HA, Reynolds TB, Henderson B, Benton B (1977) Regression of liver cell adenomas associated with oral contraceptives. Ann Internal Med 86: 180–182.Google Scholar
  15. 15.
    Penkava RR, Rothenberg J (1981) Spontaneous resolution of oralcontraceptive-associated liver tumor. J Computer Assisted Tomog 5: 102–103.CrossRefGoogle Scholar
  16. 16.
    Rooks JB, Ory AW, Ishak KG, Strauss LT (1979) Epidemiology of hepatocellular adenomas. JAMA 242: 644–648.PubMedCrossRefGoogle Scholar
  17. 17.
    Neuberger J, Forman D, Doll R, Williams R (1986) Oral contraceptives and hepatocellular carcinoma. Brit Med J 292: 1355–1357.CrossRefGoogle Scholar
  18. 18.
    Forman D, Vincent TJ, Doll R (1986) Cancer of the liver and the use of oral contraceptives. Brit Med J 292: 1357–1361.CrossRefGoogle Scholar
  19. 19.
    Yager JD Jr, Fifield DS Jr, (1982) Lack of hepatogenotoxicity of oral contraceptive steroids. Carcinogenesis 3: 625–628.PubMedCrossRefGoogle Scholar
  20. 20.
    Wanless, IR, Medlin A (1982) Role of estrogens as promoters of hepatic neoplasia. Lab Invest 46: 313–320.PubMedGoogle Scholar
  21. 21.
    Schuppler J, Gunzel P (1979) Liver tumors and steroidal hormones in rats and mice. Arch Toxicol Suppl 2: 181–195.PubMedCrossRefGoogle Scholar
  22. 22.
    El Etreby MF (1980) Influence of contraceptive steroids on tumor development in experimental animals and man: a short review. In: E Gen777ani et al. Ed Pharmacological Modulation of Steroid Action, Raven Press, New York p. 239.Google Scholar
  23. 23.
    Li JJ, Li SA (1990) Estrogen carcinogenesis in hamster tissues: a critical review. Endocrine Rev 11: 524–531.CrossRefGoogle Scholar
  24. 24.
    Coe JE, Ishak KG, Ross MJ (1990) Estrogen induction of hepatocellular carcinomas in Armenian hamsters. Hepatology 11: 570–577.PubMedCrossRefGoogle Scholar
  25. 25.
    Reznik-Schuller H (1979) Carcinogenic effects of diethylstilbestrol in male Syrian golden hamsters and European hamsters. J Natl Cancer Inst 62: 1083–1088.PubMedGoogle Scholar
  26. 26.
    Pour P, Althoff J, Salmasi SZ, Stepan K (1979) Spontaneous tumors and common diseases in three type of hamsters. J Natl Cancer Inst 63: 797–811.PubMedGoogle Scholar
  27. 27.
    Li JJ, Li SA (1984) High incidence of hepatocellular carcinomas after synthetic estrogen administration in Syrian golden hamsters fed anaphthoflavone: a new tumor model. J Natl Cancer Inst 73: 543–547.PubMedGoogle Scholar

Copyright information

© Springer-Verlag New York, Inc. 1992

Authors and Affiliations

  • Jonathan J. Li
  • Hadley Kirkman
  • Sara Antonia Li

There are no affiliations available

Personalised recommendations